Jagsonpal Pharmaceuticals (BOM:507789) Moat Score: 0/10 (As of Jul. 24, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:507789 Jagsonpal Pharmaceuticals Ltd BOM:507789
69 GF Score
Price ₹217.85
GF Value ₹205.68
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is Jagsonpal Pharmaceuticals Moat Score?

Jagsonpal Pharmaceuticals has the Moat Score of 0, which implies that the company might have No Moat - No discernible moat.

Jagsonpal Pharmaceuticals has

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Jagsonpal Pharmaceuticals might have No Moat - No discernible moat.

Jagsonpal Pharmaceuticals  (BOM:507789) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Jagsonpal Pharmaceuticals Moat Score Related Terms

BOM:507789
69GF Score
Jagsonpal Pharmaceuticals Ltd BOM:507789
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Jagsonpal Pharmaceuticals (BOM:507789) Overvalued in 2026?

Based on GuruFocus' analysis, Jagsonpal Pharmaceuticals stock appears to be overvalued. The current stock price of ₹217.85 is trading 5.9% above its estimated GF Value™ of ₹205.68. GuruFocus considers Jagsonpal Pharmaceuticals to be Fairly Valued.

Key valuation signals for BOM:507789:

  • Moat Score: 0
  • GF Value™: ₹205.68 vs. price of ₹217.85 (5.9% above fair value)
  • GF Score™: 69/100 with 3 warning signs

No single metric tells the full story. See the BOM:507789 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Jagsonpal Pharmaceuticals Business Description

Other Exchanges JAGSNPHARM:India
Address 3rd Floor, Phase - IV, Udyog Vihar, Plot No. 412-415, Nimai Tower, Gurugram, HR, IND, 122015
Jagsonpal Pharmaceuticals Ltd is a pharmaceutical company. It develops and manufactures active pharmaceutical ingredients and formulations like Capsule and Tablet. The company operates in the Gynaecology, Orthopaedics, Dermatology and Paediatric segments. Its brands comprise Lycored, Maintane, Doxypal DR, and others.
69GF Score

Get the complete analysis for BOM:507789

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹217.85
Price
₹205.68
GF Value